Evidence map›Paper›PMID 36724788›Full record

ArticleCell2023

Trustworthiness matters: Building equitable and ethical science.

Jenny Reardon, Sandra Soo-Jin Lee, Sara Goering, Stephanie M Fullerton, Mildred K Cho, Aaron Panofsky, Evelynn M Hammonds

Abstract read
In one paragraph

Article in Cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Placing Publics in Public Health Genomics.Public health genomics · 2024
    Article
  9. Article
  10. Article
  11. Unbounding ELSI: The Ongoing Work of Centering Equity and Justice.The American journal of bioethics : AJOB · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jenny ReardonDepartment of Sociology, University of California, Santa Cruz, Santa Cruz, CA 95064, USA. Electronic address: reardon1@ucsc.edu.
Sandra Soo-Jin LeeDivision of Ethics, Department of Medical Humanities and Ethics, Columbia University, New York, NY 10032, USA.
Sara GoeringDepartment of Philosophy, University of Washington, Seattle, WA 98195, USA.
Stephanie M FullertonDepartment of Bioethics & Humanities, University of Washington School of Medicine, Seattle, WA 98195, USA.
Mildred K ChoStanford Center for Biomedical Ethics, Stanford University, Stanford, CA 94305, USA.
Aaron PanofskyInstitute for Society and Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Evelynn M HammondsDepartment of the History of Science, Harvard University, Cambridge, MA 02138, USA; Department of Comparative Women's Studies, Spelman College, Atlanta, GA 30314, USA.

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Post-trial obligations in neurotechnologyRF1MH117800 · NIMH · UNIVERSITY OF WASHINGTON · PI GOERING, SARA, KLEIN, ERAN · 2018 to 2020
$2.2M
NCATS NIH HHS UL1 TR001873NIMH NIH HHS RF1 MH117800
6 · The paper itself

Abstract

Trustworthy science requires research practices that center issues of ethics, equity, and inclusion. We announce the Leadership in the Equitable and Ethical Design (LEED) of Science, Technology, Mathematics, and Medicine (STEM) initiative to create best practices for integrating ethical expertise and fostering equitable collaboration.

Indexed as

LeadershipTechnologyMathematics

Identifiers

PMID36724788
PMCPMC10580253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.